Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J. Moore, Wendy R. Parulekar, Steven Gallinger et al.|Journal of Clinical Oncology|2007Cited by 3.9k